The largest analgesic and anti-inflammatory patch manufacturer, Hisamitsu Pharmaceutical <4530.T>, is showing slight movements. At one point, it reached 4,165 yen, which is up 54 yen from the previous day. After the market closed on the 10th, it announced the formulation of a basic policy regarding cash allocation.
The company plans to make growth investments of 200 billion yen (capital investment, global strategy investment, research and development investment) and more than 50 billion yen in shareholder returns (dividends, share buybacks) over five years from the fiscal year ending February 2027 to the fiscal year ending February 2031. This aims to accelerate business growth and improve capital profitability.
On this day, the market is experiencing a widespread decline, and after the buying round, the company’s stock is becoming heavy on the upside.
Provided by Wealth Advisor Company.
